Cingulate is trading 5.47% lower at $4.32, with no verified company-specific announcement explaining the October 15, 2026 decline.
- Broader risk-off pressure, including hotter-than-expected inflation and interest-rate concerns, is part of the available context but is not established as the direct cause.
- Cingulate’s press-release page lists August 13, 2026, as its latest release; the October 14 after-hours gain also had no verified company-specific catalyst.